BioRestorative Therapies (BRTX) Competitors $1.84 +0.06 (+3.37%) Closing price 03:50 PM EasternExtended Trading$1.81 -0.03 (-1.63%) As of 07:36 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock BRTX vs. OPGN, CCM, BNR, ENZ, MRAI, KDLY, MGRX, SSY, OTRK, and BGLCShould you be buying BioRestorative Therapies stock or one of its competitors? The main competitors of BioRestorative Therapies include OpGen (OPGN), Concord Medical Services (CCM), Burning Rock Biotech (BNR), Enzo Biochem (ENZ), Marpai (MRAI), Kindly MD (KDLY), Mangoceuticals (MGRX), SunLink Health Systems (SSY), Ontrak (OTRK), and BioNexus Gene Lab (BGLC). These companies are all part of the "healthcare" industry. BioRestorative Therapies vs. OpGen Concord Medical Services Burning Rock Biotech Enzo Biochem Marpai Kindly MD Mangoceuticals SunLink Health Systems Ontrak BioNexus Gene Lab BioRestorative Therapies (NASDAQ:BRTX) and OpGen (NASDAQ:OPGN) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their risk, earnings, institutional ownership, profitability, dividends, analyst recommendations, community ranking, media sentiment and valuation. Which has higher earnings and valuation, BRTX or OPGN? BioRestorative Therapies has higher earnings, but lower revenue than OpGen. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBioRestorative Therapies$401K34.44-$14.41M-$1.16-1.59OpGen$2.67M16.10-$32.67MN/AN/A Does the MarketBeat Community believe in BRTX or OPGN? OpGen received 299 more outperform votes than BioRestorative Therapies when rated by MarketBeat users. However, 100.00% of users gave BioRestorative Therapies an outperform vote while only 52.08% of users gave OpGen an outperform vote. CompanyUnderperformOutperformBioRestorative TherapiesOutperform Votes2100.00% Underperform VotesNo VotesOpGenOutperform Votes30152.08% Underperform Votes27747.92% Does the media prefer BRTX or OPGN? In the previous week, BioRestorative Therapies and BioRestorative Therapies both had 1 articles in the media. BioRestorative Therapies' average media sentiment score of 1.43 beat OpGen's score of 0.00 indicating that BioRestorative Therapies is being referred to more favorably in the media. Company Overall Sentiment BioRestorative Therapies Positive OpGen Neutral Which has more volatility & risk, BRTX or OPGN? BioRestorative Therapies has a beta of 68.9, meaning that its share price is 6,790% more volatile than the S&P 500. Comparatively, OpGen has a beta of -1.61, meaning that its share price is 261% less volatile than the S&P 500. Do analysts recommend BRTX or OPGN? BioRestorative Therapies presently has a consensus price target of $18.00, indicating a potential upside of 878.26%. Given BioRestorative Therapies' stronger consensus rating and higher probable upside, research analysts plainly believe BioRestorative Therapies is more favorable than OpGen.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score BioRestorative Therapies 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00OpGen 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Is BRTX or OPGN more profitable? OpGen has a net margin of -1,140.36% compared to BioRestorative Therapies' net margin of -2,697.08%. OpGen's return on equity of 0.00% beat BioRestorative Therapies' return on equity.Company Net Margins Return on Equity Return on Assets BioRestorative Therapies-2,697.08% -98.49% -75.23% OpGen -1,140.36%N/A -287.58% Do institutionals and insiders hold more shares of BRTX or OPGN? 69.4% of BioRestorative Therapies shares are held by institutional investors. Comparatively, 2.7% of OpGen shares are held by institutional investors. 25.5% of BioRestorative Therapies shares are held by company insiders. Comparatively, 43.8% of OpGen shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth. SummaryBioRestorative Therapies beats OpGen on 10 of the 15 factors compared between the two stocks. Get BioRestorative Therapies News Delivered to You Automatically Sign up to receive the latest news and ratings for BRTX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BRTX vs. The Competition Export to ExcelMetricBioRestorative Therapieshealth & allied services, not elsewhere classified IndustryMedical SectorNASDAQ ExchangeMarket Cap$13.81M$2.03B$5.56B$8.04BDividend YieldN/A7.12%5.09%4.22%P/E Ratio-1.2016.3222.6818.83Price / Sales34.443.88404.28106.72Price / CashN/A9.3238.1834.62Price / Book0.754.046.794.33Net Income-$14.41M$87.49M$3.22B$247.97M7 Day Performance7.60%1.42%2.44%2.71%1 Month Performance-0.54%-4.98%3.78%3.37%1 Year Performance26.03%-25.76%17.05%5.80% BioRestorative Therapies Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BRTXBioRestorative Therapies3.9929 of 5 stars$1.84+3.4%$18.00+878.3%+29.9%$13.81M$401,000.00-1.207Short Interest ↓OPGNOpGenN/A$4.99+0.4%N/A+25.7%$41.70M$2.67M0.00100CCMConcord Medical Services0.5899 of 5 stars$7.67+27.5%N/A-12.9%$33.89M$471.70M0.00970Short Interest ↑Gap UpHigh Trading VolumeBNRBurning Rock Biotech1.8775 of 5 stars$2.95+1.9%N/A-61.6%$30.17M$515.82M-0.981,390Short Interest ↓Positive NewsENZEnzo Biochem0.5505 of 5 stars$0.33-14.8%N/A-68.8%$17.03M$29.09M0.00520Analyst ForecastGap DownHigh Trading VolumeMRAIMarpaiN/A$1.00flatN/A-50.2%$14.90M$34.87M-0.38150Upcoming EarningsKDLYKindly MD1.2786 of 5 stars$1.77-0.9%N/AN/A$10.70M$2.72M-2.69N/AShort Interest ↓Positive NewsMGRXMangoceuticals0.918 of 5 stars$1.75-1.7%N/A-97.3%$9.07M$615,873.00-0.303Short Interest ↓SSYSunLink Health SystemsN/A$0.97-0.4%N/A+60.5%$6.85M$31.23M6.951,376OTRKOntrak3.2771 of 5 stars$1.50+0.4%$45.00+2,908.0%-63.8%$6.31M$10.85M-0.14250BGLCBioNexus Gene Lab0.2676 of 5 stars$2.83+4.4%N/A-54.6%$5.03M$9.51M0.0030News CoverageGap Down Related Companies and Tools Related Companies OpGen Competitors Concord Medical Services Competitors Burning Rock Biotech Competitors Enzo Biochem Competitors Marpai Competitors Kindly MD Competitors Mangoceuticals Competitors SunLink Health Systems Competitors Ontrak Competitors BioNexus Gene Lab Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:BRTX) was last updated on 5/2/2025 by MarketBeat.com Staff From Our PartnersElon’s Terrifying Warning Forces Trump To Take ActionElon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredTrump Orders 'National Digital Asset Stockpile'Billionaires Rush Into Digital Banking Token Three massive forces are converging right now, creating what c...Crypto 101 Media | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredHere’s How to Claim Your Stake in Elon’s Private Company, xAII predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioRestorative Therapies, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share BioRestorative Therapies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy BRTX Stock Free BRTX Stock Alerts